US Patent

US11179465 — Topical compositions comprising a corticosteroid

Method of Use · Assigned to PRIMUS PHARMACEUTICALS Inc · Expires 2030-08-31 · 4y remaining

Vulnerability score 64/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects topical compositions that include a corticosteroid, at least one alcohol, and a penetration-enhancing agent.

USPTO Abstract

Topical compositions comprising a corticosteroid, at least one alcohol, and a penetration enhancing agent.

Drugs covered by this patent

Temovate (CLOBETASOL PROPIONATE) · Fougera Pharms

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-1858`	—	Temovate

Patent Metadata

Patent number: US11179465
Jurisdiction: US
Classification: Method of Use
Expires: 2030-08-31
Drug substance claim: No
Drug product claim: Yes
Assignee: PRIMUS PHARMACEUTICALS Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.